COVID-19 vaccine: Benefits outweighs the risk of Bell's palsy, finds Lancet study
China: The beneficial and protective effects of the inactivated COVID-19 vaccine far outweigh the risk of Bell's palsy-- this is the main key takeaway from a recent study in The Lancet Infectious Diseases journal. Bell's palsy is a rare and transient adverse event following immunization.
According to the study, there is an overall increase in the risk of Bell's palsy after CoronaVac vaccination (inactivated SARS-CoV 2 vaccine) but not after BNT162b2 (mRNA vaccine) vaccination. However, the researchers add that there is a need for additional studies to be conducted in other regions to confirm the findings.
The study which is the first large-scale population-based study on the association between the SARS-CoV-2 vaccines and Bell's palsy found that for every 100,000 people vaccinated with inactivated vaccine, CoronaVac, an additional 4.8 people may develop the condition.